The field of cardiovascular medicine is undergoing a transformative shift towards
personalized medicinal therapy, particularly in the context of post stent implantation. This …

Drug-eluting stents have transformed the treatment of coronary artery disease (CAD), and
there are two types: polymer-free and polymer-coated stents. Polymer-free stents have a …

Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …

Background A 1-year follow-up, polymer-free metallic stent coated with biolimus-A9 followed
by 1-month dual antiplatelet therapy is safer and more effective than a bare-metal stent …

Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal
stents (BMS) because of their better ability to control restenosis. However, recognized …

Introduction: Percutaneous coronary intervention (PCI) is 40 years old this year. From its
humble beginnings of experimental work, PCI has transitioned over years with coronary …

Chronic kidney disease (CKD) affects 13% of the US population. 1 Although a significant
proportion of these patients progress to end-stage renal disease (ESRD) requiring renal …

Clinical evaluations have proven the efficacy of drug-elution stents (DES) in reduction of in-
stent restenosis rates as compared to drug-free bare metal stents (BMS). Typically, DES are …

Cerebrovascular disease involves various medical disorders that obstruct brain blood
vessels or deteriorate cerebral circulation, resulting in ischemic or hemorrhagic stroke …

Objectives: The purpose of this study was to evaluate the efficacy and long-term outcomes of
a novel polymer/carrier-free drug-coated stent (DCS) in patients with de novo coronary …